Marı́a G. Juarranz

Author

Marı́a G. Juarranz

Universidad de Alcalá

Also Known As

Maria G. Juarranz, Maria Guillerma Juarranz, María G Juarranz, María G. Juarranz, Marı́a G Juarranz, Marı́a G. Juarranz

Publications

783

Citations

H-Index

Concepts

All Affiliations

Universidad de Alcalá Université Libre de Bruxelles Universidad Complutense de Madrid

About

Marı́a G. Juarranz is an author at Universidad de Alcalá specializing in medicine, endocrinology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	315
2	Endocrinology	2	2	61
3	Cell Biology	1	1	39
4	Cellular Physiology	1	1	39
5	Gastroenterology	1	1	254

Marı́a G. Juarranz

Publications

757

Citations

H-Index

Page 1

	Year	Citations
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease Catalina Abad, Carmen Martínez, Marı́a G. Juarranz, Gastroenterology InflammationAutoimmune DiseaseMedicineImmunologyGastroenterology	2003	254
Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor Carmen Martínez, Catalina Abad, Mario Delgado, Proceedings of the National Academy of Sciences	2002	115
Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction Rosa M. Solano, Ingrid Langer, Jason Perret, Journal of Biological Chemistry	2001	81
VIP and PACAP are autocrine factors that protect the androgen‐independent prostate cancer cell line PC‐3 from apoptosis induced by serum withdrawal Irene Gutiérrez‐Cañas, Nieves Rodríguez‐Henche, Oscar R. Bolanos, British Journal of Pharmacology	2003	63
Pituitary Adenylate-Cyclase-Activating Polypeptide Expression in the Immune System Catalina Abad, Carmen Martínez, Javier Leceta, NeuroImmunoModulation	2002	52
Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K Irene Gutiérrez‐Cañas, Marı́a G. Juarranz, Beatriz Collado, The Prostate	2004	49
Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors Marı́a G. Juarranz, Oscar R. Bolanos, Irene Gutiérrez‐Cañas, Cellular Signalling Pacap ReceptorsUrologySignal TransductionG Protein-coupled ReceptorHormonal Receptor	2001	39
Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC<sub>2</sub>-Selective Ligands Marı́a G. Juarranz, Jean Van Rampelbergh, Philippe Gourlet, Molecular Pharmacology	1999	37
Vasoactive intestinal polypeptide VPAC<sub>1</sub> and VPAC<sub>2</sub> receptor chimeras identify domains responsible for the specificity of ligand binding and activation Marı́a G. Juarranz, Jean Van Rampelbergh, Philippe Gourlet, European Journal of Biochemistry	1999	29
Expression of vasoactive intestinal peptide (VIP) receptors in human uterus Ana M. Bajo, Marı́a G. Juarranz, Pedro L. Valenzuela, Peptides NeuropeptidesMedicinePhysiologyUterine ReceptivityGynecology	2000	22

Page 1